Loss of defense against stress: Diabetes and heat shock proteins

Diabetes Technology and Therapeutics

Volumn 7, Issue 1, 2005, Pages 204-208

  Hooper, Philip L ^a,c   Hooper, Joanna J ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BIMOCLOMOL; CARVEDILOL; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PENTOXIFYLLINE; PROTEIN HEAT SHOCK FACTOR 1; THIOCTIC ACID; UNCLASSIFIED DRUG;

DIABETES MELLITUS; DISEASE COURSE; EXERCISE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MEMBRANE FLUIDITY; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS; HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; MEMBRANE FLUIDITY; MODELS, ANIMAL;

EID: 14844356006     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2005.7.204     Document Type: Note

References (34)

1. Tytell M, Hooper PL: Heat shock proteins: new keys to the development of cytoprotective therapies. Emerg Ther Targets 2001;5:267-287.
2. Taylor R: Causation of type 2 diabetes - the Gordian knot unravels. N Engl J Med 2004;350:639-641.
3. Hsu AL, Murphy CT, Kenyon C: Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 2003;300:1142-1145.
4. Pittet JF, Lee H, Morabito D, Howard MB, Welch WJ, Mackersie RC: Serum levels of Hsp 72 measured early after trauma correlate with survival. J Trauma 2002;52:611-617; discussion 617.
5. Atalay M, Oksala NK, Laaksonen DE, Khanna S, Nakao C, Lappalainen J, Roy S, Hanninen O, Sen CK: Exercise training modulates heat shock protein response in diabetic rats. J Appl Physiol 2004;97:605-611.
6. Shan YX, Yang TL, Mestril R, Wang PH: Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle: implications on decreased myocardial protection in diabetic cardiomyopathy. J Biol Chem 2003;278:45492-45498.
7. Strokov IA, Manukhina EB, Bakhtina LY, Malyshev IY, Zoloev GK, Kazikhanova SI, Ametov AS: The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: effect of antioxidant therapy. Bull Exp Biol Med 2000;130:986-990.
8. Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, Bonner-Weir S, Polonsky KS: Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 1998;47:358-364.
9. Kurucz I, Morva A, Vaag A, Eriksson KF, Huang X, Groop L, Koranyi L: Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 2002;51:1102-1109.
10. Bruce CR, Carey AL, Hawley JA, Febbraio MA: Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 2003;52:2338-2345.
11. Febbraio MA, Ott P, Nielsen HB, Steensberg A, Keller C, Krustrup P, Secher NH, Pedersen BK: Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. J Physiol 2002;544:957-962.
12. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003;100:8466-8471.
13. Housby JN, Cahill CM, Chu B, Prevelige R, Bickford K, Stevenson MA, Calderwood SK: Non-steroidal anti-inflammatory drugs inhibit the expression of cytokines and induce HSP70 in human monocytes. Cytokine 1999;11:347-358.
14. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
15. Tong P, Thomas T, Berrish T, Humphriss D, Barriocanal L, Stewart M, Walker M, Wilkinson R, Alberti KG: Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet 1995;345:357-358.
16. Hooper PL: Hot-tub therapy for type 2 diabetes mellitus. N Engl J Med 1999;341:924-925.
17. Perdrizet GA, Rewinski MJ, Schweizer RT, Scharp DW: Heat shock and recovery protects pancreatic islets from warm ischemic injury. Transplant Proc 1994;26:3477-3478.
18. Hargitai J, Lewis H, Boros I, Racz T, Fiser A, Kurucz I, Benjamin I, Vigh L, Penzes Z, Csermely P, Latchman DS: Bimoclomol, a heat shock protein co-inducer, acts by the prolonged activation of heat shock factor-1. Biochem Biophys Res Commun 2003;307:689-695.
19. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997;20:614-620.
20. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A: Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003;362:7-13.
21. Coimbra R, Melbostad H, Hoyt DB: Effects of phosphodiesterase inhibition on the inflammatory response after shock: role of pentoxifylline. J Trauma 2004;56:442-449.
22. Calo L, Giacon B, Davis PA, Pagnin E, Piccin A, Riegler P, Huber W, Antonello A, Semplicini A: Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine. Clin Nephrol 2002;58:103-110.
23. Weber SM, Chambers KT, Bensch KG, Scarim AL, Corbett JA: PPAR-γ ligands induce ER stress in pancreatic β-cells: ER stress activation results in the attenuation of cytokine signaling. Am J Physiol Endocrinol Metab 2004;287:E1171-1177. Epub 2004 Aug 17.
24. Ovalle F, Bell DS: Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitus. Diabetes Obes Metab 2002;4:56-59.
25. Hooper PL: Diabetes, nitric oxide, and heat shock proteins. Diabetes Care 2003;26:951-952.
26. Furchgott RF, Jothianandan D: Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 1991;28:52-61.
27. Leonard DR, Farooqi MH, Myers S: Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomized, placebo-controlled study with monochromatic near-infrared treatment. Diabetes Care 2004;27:168-172.
28. Meldrum KK, Burnett AL, Meng X, Misseri R, Shaw MB, Gearhart JP, Meldrum DR: Liposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-kappaB activation, tumor necrosis factor-alpha production, and subsequent ischemia-induced apoptosis. Circ Res 2003;92:293-929.
29. Radak Z, Chung HY, Naito H, Takahashi R, Jung KJ, Kim HJ, Goto S: Age-associated increase in oxidative stress and nuclear factor kappaB activation are attenuated in rat liver by regular exercise. FASEB J 2004;18:749-750.
30. Heneka MT, Gavrilyuk V, Landreth GE, O'Banion MK, Weinberg G, Feinstein DL: Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression. J Neurochem 2003;85:387-398.
31. Yang SP, Ho LJ, Lin YL, Cheng SM, Tsao TP, Chang DM, Hsu YL, Shih CY, Juan TY, Lai JH: Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity. Cardiovasc Res 2003;59:776-787.
32. Chen YM, Tu CJ, Hung KY, Wu KD, Tsai TJ, Hsieh BS: Inhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-kappa B down-regulation. Br J Pharmacol 2003;138:950-958.
33. Chen HS, Shan YX, Yang TL, Lin HD, Chen JW, Lin SJ, Wang PH. Insulin Deficiency Downregulated Heat Shock Protein 60 and IGF-1 Receptor Signaling in Diabetic Myocardium. Diabetes 2005;54:175-81.
34. Vigh L, Maresca B, Harwood JL. Does the membrane's physical state control the expression of heat shock and other genes? Trends Biochem Sci 1998;23:369-74.